Overview

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

Status:
Not yet recruiting

Trial end date:
2023-12-02

Target enrollment:

Participant gender:

Summary

Investigate the protective effect of chronic MitoQ supplementation on cardiovascular toxicity induced by doxorubicin-based adjuvant chemotherapy in breast cancer patients.

Phase:

N/A

Details

Lead Sponsor:

D'Or Institute for Research and Education

Collaborators:

InCor Heart Institute
Instituto do Cancer do Estado de São Paulo